Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFranchise Brands Regulatory News (FRAN)

Share Price Information for Franchise Brands (FRAN)

Share Price is delayed by 15 minutes
Get Live Data
142.00    0.00 (0.00%)
Bid:
142.50
Ask:
148.00
Spread: 5.50 (3.86%)
Market Cap: £272.19m
FRAN Live PriceLast checked at - London Stock Exchange

Intraday Franchise Brands Share Chart

Share Purchase Programme

24 Jun 2022 16:45

RNS Number : 1858Q
Franchise Brands PLC
24 June 2022
 

24 June 2022

FRANCHISE BRANDS PLC

("Franchise Brands", "the Group" or "the Company")

 

Share purchase programme

 

Franchise Brands plc (AIM: FRAN), an international multi-brand franchise business, announces that it will continue its discretionary programme to buy ordinary shares of 0.5p each in the Company ("Ordinary Shares") for the next six-month period from 1 July 2022 to 31 December 2022, up to an aggregate value of £1,500,000 (the "Programme").

The Trustee of the Franchise Brands PLC Employee Benefit Trust (the "EBT") will purchase Ordinary Shares in accordance with the Programme. The Programme seeks to mitigate the dilutive impact of share option awards and to improve overall shareholder return.

During the period 1 January 2022 to 24 June 2022 ("H1 2022"), the EBT has purchased 427,469 Ordinary Shares at an average price of 139 pence per share. 110,921 Ordinary Shares held by the EBT have been used to satisfy the exercise of options over Ordinary Shares. Accordingly, the EBT currently holds 535,788 Ordinary Shares (31 December 2021: 219,240 Ordinary Shares) which represents 0.41 per cent. (31 December 2021: 0.23 per cent.) of the Company's current issued share capital. The net cash cost to the Company during H1 2022 was £445,552.

The Trustees of the EBT have entered into arrangements with the Company's joint broker, Dowgate Capital Limited ("Dowgate"), to carry out on-market purchases of Ordinary Shares under the Programme, including on a discretionary basis independent of the Company during any prohibited periods of the Company, as determined by the UK Market Abuse Regulation, which may fall during the period of the Programme.

 

Enquiries:

Franchise Brands plc

+ 44 (0) 1625 813231

Stephen Hemsley, Executive Chairman

Brian Hogan, Chief Financial Officer

Julia Choudhury, Corporate Development Director

 

Allenby Capital Limited (Nominated Adviser and Joint Broker)

+44 (0) 20 3328 5656

Jeremy Porter / Liz Kirchner (Corporate Finance)

Amrit Nahal (Sales and Corporate Broking)

 

Dowgate Capital Limited (Joint Broker)

+44 (0) 20 3903 7715

James Serjeant / Colin Climie / Nicholas Chambers

 

MHP Communications (Financial PR)

+44 (0) 20 3128 8100

Katie Hunt / Catherine Chapman

+44 (0) 7884 494112

 

franchisebrands@mhpc.com

 

 About Franchise Brands plc

Franchise Brands is focused on building market-leading businesses in selected customer segments, primarily via a franchise model. The Group currently has a combined network of over 600 franchisees across six principal franchise brands in the UK, North America and Europe. Our focus is on established brands which can benefit from our shared support services, specialist sector expertise, management experience and group resources.

Our B2B brands are Metro Rod, Metro Plumb, Filta, Willow Pumps and Azura, and our principle B2C brands are ChipsAway, Ovenclean and Barking Mad. Each of our brands are leaders in their respective markets. The combined trading history of all the Group's brands is over 190 years. Franchise Brands employs over 430 people from 5 principal offices in the UK as well as Orlando, Florida and the Netherlands.

 

For further information, visit www.franchisebrands.co.uk .

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFLFVERTISFIF
Date   Source Headline
25th Feb 20253:47 pmRNSHolding(s) in Company
20th Feb 20252:30 pmRNSCapital Markets Day
13th Feb 20257:00 amRNSAppointment of CFO and Group Finance Director
11th Feb 20257:00 amRNSDirector/PDMR Shareholding
7th Feb 20257:00 amRNS-RCapital Markets Day
31st Jan 20257:00 amRNSDirectors’ dealings
28th Jan 20257:00 amRNSTrading Update
16th Jan 20257:00 amRNSAppointment of Non-Executive Director
13th Nov 20242:00 pmRNSGrant of Options to director
12th Nov 20247:00 amRNSQ3 Trading Update
23rd Oct 20247:00 amRNSGroup CEO Appointment and Listing Consideration
15th Oct 20247:00 amRNSRe-commencement of Share purchase programme
23rd Sep 202411:54 amRNSHolding(s) in Company
20th Sep 20247:00 amRNSDirector/PDMR shareholding & holding in Company
17th Sep 20247:00 amRNSInterim Results
9th Sep 20247:00 amRNSNotice of Interim Results
30th Jul 20248:33 amRNSDirector/PDMR Shareholding
18th Jul 20241:55 pmRNSResult of AGM
18th Jul 20247:00 amRNSAGM Statement and Trading Update
8th Jul 20241:42 pmRNSGrant of Options
27th Jun 202410:01 amRNSAnnual General Meeting and proxy voting deadline
21st Jun 20244:40 pmRNSPublication of Annual Report and Accounts
20th Jun 20247:01 amRNSBoard and management changes
20th Jun 20247:00 amRNSFinal Results
3rd Jun 20247:00 amRNSTrading Update, Final Dividend & AGM
4th Apr 20243:02 pmRNSHolding(s) in Company
20th Feb 20242:45 pmRNSCapital Markets Day
18th Jan 20247:00 amRNSCapital Markets Day
18th Jan 20247:00 amRNSTrading Update
16th Jan 20245:12 pmRNSHolding(s) in Company
21st Nov 20237:00 amRNSInvestor presentation
15th Nov 20233:11 pmRNSHolding(s) in Company
25th Oct 20237:00 amRNSQ3 Trading Update
4th Sep 20237:00 amRNSBoard and management update
4th Aug 20237:00 amRNSDirector/PDMR Shareholding and Grant of Options
27th Jul 20237:01 amRNSAppointment of Chief Financial Officer
27th Jul 20237:00 amRNSInterim Results
25th Jul 20231:51 pmRNSInvestor Presentation via Investor Meet Company
5th Jul 20237:00 amRNSNotice of Interim Results
26th Jun 20237:00 amRNSShare Purchase Programme
1st Jun 20237:00 amRNSDirector/PDMR Shareholding
18th May 202310:10 amRNSHolding(s) in Company
10th May 20235:54 pmRNSGrant of options & director holdings
4th May 20237:00 amRNSInvestor Presentation
28th Apr 20235:00 pmRNSTotal Voting Rights
25th Apr 20234:09 pmRNSHolding(s) in Company
24th Apr 20231:55 pmRNSHolding(s) in Company
20th Apr 20239:33 amRNSResult of GM, Completion of Acquisition and TVR
18th Apr 20231:56 pmRNSResult of AGM
18th Apr 20237:00 amRNSAGM Statement and Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.